STOCK TITAN

ACMR insider sale notice — 30,000 shares valued at $960,000

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ACM Research, Inc. (ACMR) Form 144 notice: An individual plans to sell 30,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $960,000. The filing lists 64,180,965 shares outstanding, making the proposed sale roughly 0.0467% of outstanding shares. The securities were reported as acquired by stock option exercise with a purchase date and payment date shown as 08/25/2025. The filing also discloses a sale of 30,000 shares by Jian Wang on 08/22/2025 for gross proceeds of $900,012. The notice includes the required representation that the seller does not possess undisclosed material information.

Positive

  • None.

Negative

  • Insider sale disclosed: Proposed sale of 30,000 shares with aggregate market value of $960,000.
  • Recent disposition noted: Jian Wang sold 30,000 shares on 08/22/2025 for $900,012.

Insights

TL;DR: Routine insider transaction: option exercise and subsequent planned sale of 30,000 shares, small versus float.

The filing documents a common insider activity: exercising stock options and selling the resulting shares through a broker. The aggregate value of the planned sale is $960,000, representing about 0.0467% of the company's reported outstanding shares, which is immaterial to overall share count. The separate prior sale by Jian Wang on 08/22/2025 for $900,012 is disclosed, suggesting recent insider dispositions. This filing is procedural and provides no new operational or financial data about ACMR.

TL;DR: Disclosure meets Rule 144 mechanics; no indication of undisclosed material information in the notice.

The Form 144 includes required transaction details: acquisition via stock option exercise, payment method (cash), broker name and address, and planned sale timing and market value. It contains the seller's representation about material nonpublic information and references potential Rule 10b5-1 plan adoption without providing a plan date. From a governance perspective, the filing is complete for compliance purposes but does not state whether a trading plan governs the timing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ACMR Form 144 disclose about the planned sale?

The filing discloses a planned sale of 30,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $960,000.

How were the shares being sold acquired according to the filing?

The shares were acquired by stock option exercise with an acquisition and payment date listed as 08/25/2025.

Who is listed as a recent seller in the Form 144?

The filing lists Jian Wang as having sold 30,000 common shares on 08/22/2025 for gross proceeds of $900,012.

What portion of ACMR's outstanding shares does the planned sale represent?

The planned sale of 30,000 shares represents approximately 0.0467% of the reported 64,180,965 shares outstanding.

Does the filing state whether a Rule 10b5-1 trading plan was used?

The form includes a field for the date of plan adoption or instruction if relying on Rule 10b5-1, but no plan adoption date is provided in the filing.
Acm Research

NASDAQ:ACMR

ACMR Rankings

ACMR Latest News

ACMR Latest SEC Filings

ACMR Stock Data

3.48B
51.53M
15.04%
70.31%
6.43%
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
FREMONT